Novo Nordisk A/S | DEBITO



Debt Cambiamento Data
Bausch Health Companies USD 21.51B 153M 2024-09
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 33.64B 2.52B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 56.97B 88M 2024-09
Novo Nordisk DKK 56.97B 88M 2024-09
Pacira USD 585.32M 2.04M 2024-12
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12



Novo Nordisk A/S DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.